Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study


Ahmad Awada,Agustin A Garcia,Stephen Chan,Guy H M Jerusalem,Robert E Coleman,Manon T Huizing,Aminder Mehdi,Sue M O'Reilly,John T Hamm,Peter J Barrett-Lee,Veronique Cocquyt,Kostandinos Sideras,David E Young,Carol Zhao,Yen Lin Chia,Ute Hoch, et al.


The Lancet Oncology




November 2013

Copyright © 2013, Elsevier

 User ID  
 Enable Auto Login
Forgot Password/User ID?
If you're a copyright.com user, you can login to RightsLink using your copyright.com credentials.
Already a RightsLink user or want to learn more?

Welcome to RightsLink

Elsevier has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Elsevier content. Select the "I would like to ..." drop-down menu to view the many reuse options available to you.

I would like to...


To request permission for a type of use not listed, please contact Elsevier Global Rights Department.

Are you the author of this Elsevier journal article?


Copyright © 2014 Copyright Clearance Center, Inc. All Rights Reserved. Privacy statement.
Comments? We would like to hear from you. E-mail us at customercare@copyright.com